$LGBI .003 $AHRO .115 -62%. COULD LGBI .0031 BE MY NEXT

New Post Public Reply Private Reply Replies (0) Message Board
AAAAMHIM
$LGBI .003 $AHRO .115 -62%. COULD LGBI .0031 BE MY NEXT RXMD FLCR ENIP BMIX? Got in all at BOTTOM b4 the crowd. True story. [/b]
LGBI is nice and sweet. Here are some elements and the reason I'm BUYING.

1) LGBI HAS THE LOWEST (apart from EAPH). In the MMJ OTC group, with a TINY 250 million A\S. FACT.

2) LGBI bouncing STRONG off bottom. Every time a big bid came up on Friday it got whacked and a stronger bid went higher. I put a 1.57 million bid at .0028 and sat there with my feet on the desk...not one person sold to me. Nice sweet level of .003 where you can get out 1-3 ticks with ease with not a scar.

3) Big names showing up on the LGBI IHUB board, and they haven't even LOADED yet..

4) IT'S MMJ!

5) LGBI RAN TO .008s last WEEK.

I CAN GO ON and on.

SEE YOU TUESDAY...

LGBI Analysis - Targets 0.03 / 0.045 

Contact Info 
125 Cambridge Park Drive 
Suite 301 
Cambridge, MA 02140 

Website: http://www.cannabizmobile.com 
Phone: 857-209-5053 
Email: info@cannabizmobile.com 

ShaSharere Structure 
Market Value1........$130,659 a/o Dec 26, 2014 
Authorized Shares 250,000,000 a/o Jun 27, 2014 
Shares Outstanding 37,331,190 a/o Oct 31, 2014
Float Not Available 
Par Value Not Available 

Business Entity Information 
http://nvsos.gov/sosentitysearch/CorpDetails....mp;nt7=0 

Actions\Amendments 
http://nvsos.gov/sosentitysearch/corpActions....%2c+INC. 
ABOUT CANNABIZ MOBILE INC: Cannabiz Mobile, Inc. is a mobile media and marketing Company specializing in servicing businesses in the medical marijuana industry. We market a subscription based, in the cloud, mobile media solution that enables care givers, dispensaries, hydroponic and ancillary product retailers the ability to create, deploy and analytically measure mobile marketing campaigns utilizing all networks and devices in the U.S. and Canada. Through the technology platform, and augmented by the use of custom SMS short codes, Cannabiz Mobile enables businesses to create unique customizable personal audio and video advertisements,commercials, podcasts and presentations that are accessible via all smart phone devices. Similar to a traditional email campaign Cannabiz Mobile enables their clients to build an “OPT IN” database through SMS texting. Our exclusive and custom call to action pages will direct clients’ customers to desired “actions” based upon the businesses’ unique requirements. Typical actions would include: “purchase product or service,” “download a discount coupon”, “make an appointment, reservation or donation”, “get directions or contact information”, “see customer reviews and testimonials”, “go to our website” or “go to any social media such as Facebook and Twitter.” The platform sequence allows businesses to engage the viewer with a customized audio/video message and then redirect the viewer to a CALL TO ACTION page to transact. Cannabiz Mobile designs both generic action pages and custom mobile optimized websites in which the end user has the ability to save the Mobile APP to their home screen. Every OPT-IN added to the customer database can now be reached back via text/sms with deals, discounts, loyalty rewards, mobile coupons, text-to-win campaigns, reminders, events and offers. Cannabiz Mobile clients are provided multiple layers of analytics to gauge their marketing spend and calculate ROI in real time.


$AHRO CLOSED DOWN 62% BIO company with patents for life threatening diseases... any one of these pan out $8 stock....praying....lol. ONLY 100 MILLION A\S.


https://m.facebook.com/events/435177246637389...ser_joined
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading